223 related articles for article (PubMed ID: 21199899)
1. A unique role of the cholera toxin A1-DD adjuvant for long-term plasma and memory B cell development.
Bemark M; Bergqvist P; Stensson A; Holmberg A; Mattsson J; Lycke NY
J Immunol; 2011 Feb; 186(3):1399-410. PubMed ID: 21199899
[TBL] [Abstract][Full Text] [Related]
2. Mast cells contribute to the mucosal adjuvant effect of CTA1-DD after IgG-complex formation.
Fang Y; Larsson L; Mattsson J; Lycke N; Xiang Z
J Immunol; 2010 Sep; 185(5):2935-41. PubMed ID: 20675596
[TBL] [Abstract][Full Text] [Related]
3. The ADP-ribosylating CTA1-DD adjuvant enhances T cell-dependent and independent responses by direct action on B cells involving anti-apoptotic Bcl-2- and germinal center-promoting effects.
Agren L; Sverremark E; Ekman L; Schön K; Löwenadler B; Fernandez C; Lycke N
J Immunol; 2000 Jun; 164(12):6276-86. PubMed ID: 10843681
[TBL] [Abstract][Full Text] [Related]
4. Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.
Mattsson J; Yrlid U; Stensson A; Schön K; Karlsson MC; Ravetch JV; Lycke NY
J Immunol; 2011 Oct; 187(7):3641-52. PubMed ID: 21880985
[TBL] [Abstract][Full Text] [Related]
5. IL-21 receptor is critical for the development of memory B cell responses.
Rankin AL; MacLeod H; Keegan S; Andreyeva T; Lowe L; Bloom L; Collins M; Nickerson-Nutter C; Young D; Guay H
J Immunol; 2011 Jan; 186(2):667-74. PubMed ID: 21169545
[TBL] [Abstract][Full Text] [Related]
6. Augmented antibody response with premature germinal center regression in CD40L transgenic mice.
Kishi Y; Aiba Y; Higuchi T; Furukawa K; Tokuhisa T; Takemori T; Tsubata T
J Immunol; 2010 Jul; 185(1):211-9. PubMed ID: 20505144
[TBL] [Abstract][Full Text] [Related]
7. Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit.
Agren LC; Ekman L; Löwenadler B; Lycke NY
J Immunol; 1997 Apr; 158(8):3936-46. PubMed ID: 9103464
[TBL] [Abstract][Full Text] [Related]
8. Impaired affinity maturation in Cr2-/- mice is rescued by adjuvants without improvement in germinal center development.
Wu X; Jiang N; Fang YF; Xu C; Mao D; Singh J; Fu YX; Molina H
J Immunol; 2000 Sep; 165(6):3119-27. PubMed ID: 10975825
[TBL] [Abstract][Full Text] [Related]
9. Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity.
Agren LC; Ekman L; Löwenadler B; Nedrud JG; Lycke NY
J Immunol; 1999 Feb; 162(4):2432-40. PubMed ID: 9973526
[TBL] [Abstract][Full Text] [Related]
10. Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants.
Mastelic B; Kamath AT; Fontannaz P; Tougne C; Rochat AF; Belnoue E; Combescure C; Auderset F; Lambert PH; Tacchini-Cottier F; Siegrist CA
J Immunol; 2012 Dec; 189(12):5764-72. PubMed ID: 23162125
[TBL] [Abstract][Full Text] [Related]
11. Development and maintenance of a B220- memory B cell compartment.
Driver DJ; McHeyzer-Williams LJ; Cool M; Stetson DB; McHeyzer-Williams MG
J Immunol; 2001 Aug; 167(3):1393-405. PubMed ID: 11466358
[TBL] [Abstract][Full Text] [Related]
12. CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen.
Mowat AM; Donachie AM; Jägewall S; Schön K; Löwenadler B; Dalsgaard K; Kaastrup P; Lycke N
J Immunol; 2001 Sep; 167(6):3398-405. PubMed ID: 11544331
[TBL] [Abstract][Full Text] [Related]
13. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
Lycke N
Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
[TBL] [Abstract][Full Text] [Related]
14. High affinity IgM(+) memory B cells are generated through a germinal center-dependent pathway.
Hara Y; Tashiro Y; Murakami A; Nishimura M; Shimizu T; Kubo M; Burrows PD; Azuma T
Mol Immunol; 2015 Dec; 68(2 Pt C):617-27. PubMed ID: 26514429
[TBL] [Abstract][Full Text] [Related]
15. The B cell targeted adjuvant, CTA1-DD, exhibits potent mucosal immunoenhancing activity despite pre-existing anti-toxin immunity.
Lycke N; Schön K
Vaccine; 2001 Mar; 19(17-19):2542-8. PubMed ID: 11257390
[TBL] [Abstract][Full Text] [Related]
16. Analysis of antigen-specific B-cell memory directly ex vivo.
McHeyzer-Williams LJ; McHeyzer-Williams MG
Methods Mol Biol; 2004; 271():173-88. PubMed ID: 15146121
[TBL] [Abstract][Full Text] [Related]
17. Constitutive CD40L expression on B cells prematurely terminates germinal center response and leads to augmented plasma cell production in T cell areas.
Bolduc A; Long E; Stapler D; Cascalho M; Tsubata T; Koni PA; Shimoda M
J Immunol; 2010 Jul; 185(1):220-30. PubMed ID: 20505142
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Immunization Using CTA1-DD as a Mucosal Adjuvant for an Inactivated Influenza Vaccine.
Fan XT; Wang YL; Su QD; Qiu F; Yi Y; Jia ZY; Wang DY; Qin K; Zou YN; Bi SL; Shen LP
Biomed Environ Sci; 2019 Jul; 32(7):531-540. PubMed ID: 31331437
[TBL] [Abstract][Full Text] [Related]
19. The immune complex CTA1-DD/IgG adjuvant specifically targets connective tissue mast cells through FcγRIIIA and augments anti-HPV immunity after nasal immunization.
Fang Y; Zhang T; Lidell L; Xu X; Lycke N; Xiang Z
Mucosal Immunol; 2013 Nov; 6(6):1168-78. PubMed ID: 23571505
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens.
Basu S; Ray A; Dittel BN
PLoS One; 2013; 8(6):e67587. PubMed ID: 23826323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
